Rejected at 8:20 a.m. Dec, 22, 2023 ] by thomas.holmes
Author: DillingerMed
Related Note: 1474580787193
Rationale for change

recent resources recommend using the term adherence instead of compliance

Rejection reason

no source given.

Please review the accepted sources (https://ankingmed.notion.site/AnKing-Step-Deck-Submission-Guidelines-aba538aa0e9c446897853446587bfddd).

Extra Extra
Text
What is the route of administration of leukotriene D4-receptor antagonists (e.g., montelukast, zafirlukast)?

{{c1::Oral administration}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Physeo

OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::^Systems::Respiratory::Pharmacology #AK_Step2_v12::#B&B::14_Pulmonary_Critical_Care::01_Pulmonary_Disease::02_Asthma #AK_Step1_v12::#Bootcamp::Pulmonology::05_Obstructive_Lung_Disease::03_Asthma_Treatments #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::06_Asthma_Treatment #AK_Step1_v12::#AMBOSS::eOaxrk !AK_UpdateTags::AnKing_Image::Aiman #AK_Step1_v12::^Other::^HighYield::3-HighYield-temporary #AK_Original_Decks::Step_1::Zanki_Pharmacology #PANCE::EOR::PEDS #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::06_Montelukast_&_Zafirlukast #AK_Step1_v12::#OME::PreClinical::General_Physiology::Smooth_Muscle #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::02_Allergy_&_Pulmonary::02_Asthma_therapy #AK_Step1_v12::#B&B::18_Pulm::02_Obstructive_&_Restrictive_Diseases::04_Treatment_of_COPD_&_Asthma #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::07_Asthma_Drugs !AK_UpdateTags::Step1decks::Zanki-Pharmacology #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::07_Asthma_Drugs::Antileukotrienes #AK_Step1_v12::#Physeo::^physeo_image_update